https://simplecast.com CPD In Practice In today’s medical landscape, staying current isn't just about what you know—it's about how you apply it. CPD In Practice is your direct line to the latest insights shaping health care across Canada. Hosted by Dr. Chris Morrow, Executive Medical Director of UBC's Division of Continuing Professional Development, this podcast bridges the gap between groundbreaking developments in clinical medicine and practical, practice-ready solutions. Through conversations with Canada's top medical experts, we decode topics like Generative AI in Medicine, Alcohol Use Disorder (AUD), Fetal Alcohol Spectrum Disorder (FASD) Care and more. Produced by Craig Ferguson, UBC CPD, UBC's Division of Continuing Professional Development. https://ubccpd.ca/cpd-in-practice (C) 2025 UBC Medicine Learning Network 2025 UBC Medicine Learning Network en Fri, 27 Mar 2026 19:12:41 +0000 Fri, 27 Mar 2026 19:12:51 +0000 https://cpd-in-practice.simplecast.com CPD In Practice https://image.simplecastcdn.com/images/ee2711d2-7353-4e03-96e3-6420c93bf57e/9c29f715-728f-46c8-93d4-f2f5a3e97f0d/3000x3000/podcast-thumbnail-logo-teal.jpg?aid=rss_feed https://cpd-in-practice.simplecast.com episodic In today’s medical landscape, staying current isn't just about what you know—it's about how you apply it. CPD In Practice is your direct line to the latest insights shaping health care across Canada. Hosted by Dr. Chris Morrow, Executive Medical Director of UBC's Division of Continuing Professional Development, this podcast bridges the gap between groundbreaking developments in clinical medicine and practical, practice-ready solutions. Through conversations with Canada's top medical experts, we decode topics like Generative AI in Medicine, Alcohol Use Disorder (AUD), Fetal Alcohol Spectrum Disorder (FASD) Care and more. Produced by Craig Ferguson, UBC CPD, UBC's Division of Continuing Professional Development. https://ubccpd.ca/cpd-in-practice (C) 2025 UBC Medicine Learning Network UBC CPD false https://feeds.simplecast.com/16xcJua_ professional development, ubc cpd UBC Medicine Learning Network stephen.gillis@ubc.ca 598fdedf-2f3b-4700-8ddf-a66e1308d05e S1 E5: Alcohol Use Disorder Part 2: Treatment, Medications, and Managing Withdrawal w/Dr. Randal Mason

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Fri, 27 Mar 2026 19:12:41 +0000 stephen.gillis@ubc.ca (Dr. Chris Morrow, Dr. Randal Mason) https://cpd-in-practice.simplecast.com/episodes/s1-e5-alcohol-use-disorder-part-2-treatment-medications-and-managing-withdrawal-w-dr-randal-mason-qbwJIwko

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> S1 E5: Alcohol Use Disorder Part 2: Treatment, Medications, and Managing Withdrawal w/Dr. Randal Mason Dr. Chris Morrow, Dr. Randal Mason 00:28:18 In this second episode of a two-part series on Alcohol Use Disorder (AUD) in British Columbia, addiction medicine physician Dr. Randal Mason returns to dive deeper into the practical realities of treatment. He challenges the traditional "all-or-nothing" view of recovery, explaining how harm reduction and patient-defined goals are reshaping clinical approaches. Dr. Mason walks through evidence-based pharmacological options — including naltrexone, acamprosate, gabapentin, and topiramate — and makes the case that these medications are safe and effective enough to be managed in primary care settings. The conversation also covers the complexities of alcohol withdrawal, how to use the CIWA score to determine the appropriate level of care, and when outpatient withdrawal management is a reasonable option. Throughout, Dr. Mason emphasizes the importance of combining pharmacotherapy with motivational interviewing, patient goal-setting, and realistic hope — even in the most challenging cases. © UBC Faculty of Medicine All Rights Reserved In this second episode of a two-part series on Alcohol Use Disorder (AUD) in British Columbia, addiction medicine physician Dr. Randal Mason returns to dive deeper into the practical realities of treatment. He challenges the traditional "all-or-nothing" view of recovery, explaining how harm reduction and patient-defined goals are reshaping clinical approaches. Dr. Mason walks through evidence-based pharmacological options — including naltrexone, acamprosate, gabapentin, and topiramate — and makes the case that these medications are safe and effective enough to be managed in primary care settings. The conversation also covers the complexities of alcohol withdrawal, how to use the CIWA score to determine the appropriate level of care, and when outpatient withdrawal management is a reasonable option. Throughout, Dr. Mason emphasizes the importance of combining pharmacotherapy with motivational interviewing, patient goal-setting, and realistic hope — even in the most challenging cases. © UBC Faculty of Medicine All Rights Reserved ubc cpd, ubc faculty of medicine, ubc cpd in practice, alcholism false full 5 1 1de04e5d-c5ad-4841-8cf7-339f18cc9865 S1 E4: Alcohol Use Disorder Part 1: Practical Tools for a Complex Condition w/Dr. Randal Mason Guest: Dr. Elizabeth Baerg Hall
Host: Dr. Randal Mason
Producer: Craig Ferguson
Music: "Stand With Me" by Adrian Walther licensed via SoundStripe

Episode Timestamps
[00:00] – Introduction and episode overview
[01:09] – The scale of alcohol-related harms in BC and Canada
[02:21] – Why screening remains inconsistent in clinical practice
[04:10] – Screening at every point of care
[04:32] – Clinician discomfort and workflow barriers
[05:42] – New guidance on alcohol-related risk
[07:36] – Understanding risk thresholds: cancer and cardiovascular disease
[08:16] – Patient reactions and clarifying misconceptions
[09:03] – BC guidelines compared with Canadian guidelines
[10:28] – Screening tools: SASQ, AUDIT, AUDIT-C, DSM-5 criteria
[12:30] – Treatment approaches for high-risk drinking vs. diagnosed AUD
[13:21] – Challenges for rural and remote patients and providers
[15:13] – Considerations for Indigenous patients and culturally safe care
[20:34] – Using frameworks like the Five A's in clinical conversations
[21:20] – Closing remarks and preview of Part 2
[21:31] – Knowledge nugget: the history of alcohol and the origin of "toasting"
[22:10] – Credits and CME information

Studies & Research Mentioned
• Province of British Columbia. High‑Risk Drinking and Alcohol Use Disorder. BC Guidelines; 2024. Accessed January 29, 2026. https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/high-risk-drinking-and-alcohol-use-disorder
• Wood E, Bright J, Hsu K, et al; Canadian Alcohol Use Disorder Guideline Committee. Canadian guideline for the clinical management of high‑risk drinking and alcohol use disorder. CMAJ. 2023;195(40):E1364‑E1379. doi:10.1503/cmaj.230715. https://www.cmaj.ca/content/195/40/E1364
• Canadian Centre on Substance Use and Addiction (CCSA). Canada’s Guidance on Alcohol and Health. 2023. Accessed January 29, 2026. https://www.ccsa.ca/en/guidance-tools-resources/substance-use-and-addiction/alcohol/canadas-guidance-alcohol-and-health [
• World Health Organization. AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. 2nd ed. WHO; 2001. https://www.who.int/publications/i/item/WHO-MSD-MSB-01.6a
• U.S. Department of Veterans Affairs. Alcohol Use Disorders Identification Test – Consumption (AUDIT‑C). Updated March 2021. Accessed January 29, 2026. https://www.hepatitis.va.gov/alcohol/treatment/audit-c.asp
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, Text Revision (DSM‑5‑TR). American Psychiatric Association; 2022. Information and updates available at: https://www.psychiatry.org/psychiatrists/practice/dsm
• UBC Continuing Professional Development. Alcohol Use: Screening, Determining Risk, and Evidence‑Based Treatment. Accessed January 29, 2026.

https://ubccpd.ca/learn/learning-activities/course?eventtemplate=724-alcohol-use-screening-determining-risk-and-evidencebased-treatment

© UBC Faculty of Medicine All Rights Reserved


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Fri, 27 Feb 2026 08:00:00 +0000 stephen.gillis@ubc.ca (Dr. Chris Morrow, Dr. Randal Mason) https://cpd-in-practice.simplecast.com/episodes/s1-e4-alcohol-use-disorder-part-1-practical-tools-for-a-complex-condition-w-dr-randal-mason-1es_HcTM Guest: Dr. Elizabeth Baerg Hall
Host: Dr. Randal Mason
Producer: Craig Ferguson
Music: "Stand With Me" by Adrian Walther licensed via SoundStripe

Episode Timestamps
[00:00] – Introduction and episode overview
[01:09] – The scale of alcohol-related harms in BC and Canada
[02:21] – Why screening remains inconsistent in clinical practice
[04:10] – Screening at every point of care
[04:32] – Clinician discomfort and workflow barriers
[05:42] – New guidance on alcohol-related risk
[07:36] – Understanding risk thresholds: cancer and cardiovascular disease
[08:16] – Patient reactions and clarifying misconceptions
[09:03] – BC guidelines compared with Canadian guidelines
[10:28] – Screening tools: SASQ, AUDIT, AUDIT-C, DSM-5 criteria
[12:30] – Treatment approaches for high-risk drinking vs. diagnosed AUD
[13:21] – Challenges for rural and remote patients and providers
[15:13] – Considerations for Indigenous patients and culturally safe care
[20:34] – Using frameworks like the Five A's in clinical conversations
[21:20] – Closing remarks and preview of Part 2
[21:31] – Knowledge nugget: the history of alcohol and the origin of "toasting"
[22:10] – Credits and CME information

Studies & Research Mentioned
• Province of British Columbia. High‑Risk Drinking and Alcohol Use Disorder. BC Guidelines; 2024. Accessed January 29, 2026. https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/high-risk-drinking-and-alcohol-use-disorder
• Wood E, Bright J, Hsu K, et al; Canadian Alcohol Use Disorder Guideline Committee. Canadian guideline for the clinical management of high‑risk drinking and alcohol use disorder. CMAJ. 2023;195(40):E1364‑E1379. doi:10.1503/cmaj.230715. https://www.cmaj.ca/content/195/40/E1364
• Canadian Centre on Substance Use and Addiction (CCSA). Canada’s Guidance on Alcohol and Health. 2023. Accessed January 29, 2026. https://www.ccsa.ca/en/guidance-tools-resources/substance-use-and-addiction/alcohol/canadas-guidance-alcohol-and-health [
• World Health Organization. AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. 2nd ed. WHO; 2001. https://www.who.int/publications/i/item/WHO-MSD-MSB-01.6a
• U.S. Department of Veterans Affairs. Alcohol Use Disorders Identification Test – Consumption (AUDIT‑C). Updated March 2021. Accessed January 29, 2026. https://www.hepatitis.va.gov/alcohol/treatment/audit-c.asp
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, Text Revision (DSM‑5‑TR). American Psychiatric Association; 2022. Information and updates available at: https://www.psychiatry.org/psychiatrists/practice/dsm
• UBC Continuing Professional Development. Alcohol Use: Screening, Determining Risk, and Evidence‑Based Treatment. Accessed January 29, 2026.

https://ubccpd.ca/learn/learning-activities/course?eventtemplate=724-alcohol-use-screening-determining-risk-and-evidencebased-treatment

© UBC Faculty of Medicine All Rights Reserved


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> S1 E4: Alcohol Use Disorder Part 1: Practical Tools for a Complex Condition w/Dr. Randal Mason Dr. Chris Morrow, Dr. Randal Mason 00:22:40 In this first episode of a two‑part series on Alcohol Use Disorder (AUD) in British Columbia, addiction medicine physician Dr. Randal Mason explores the scale of alcohol‑related harms in Canada and why current approaches to screening and treatment remain inconsistent. He outlines common barriers clinicians face—such as discomfort raising the topic, uncertainty about which screening tools to use, and challenges integrating these conversations into busy workflows—and offers practical ways to make these discussions more routine and supportive. © UBC Faculty of Medicine All Rights Reserved In this first episode of a two‑part series on Alcohol Use Disorder (AUD) in British Columbia, addiction medicine physician Dr. Randal Mason explores the scale of alcohol‑related harms in Canada and why current approaches to screening and treatment remain inconsistent. He outlines common barriers clinicians face—such as discomfort raising the topic, uncertainty about which screening tools to use, and challenges integrating these conversations into busy workflows—and offers practical ways to make these discussions more routine and supportive. © UBC Faculty of Medicine All Rights Reserved ubc cpd, medicine, medical, ubccpd, ubc cpd in practice, ubc medicine false full 4 1 e05a13c3-403e-4d2f-ba23-3c3b90334e46 S1 E3: ADHD Across Life Transitions: Practical Approaches for Primary Care w/ Dr. Elisabeth Baerg Hall Guest: Dr. Elizabeth Baerg Hall
Host: Dr. Chris Morrow
Producer: Craig Ferguson
Music: "Stand With Me" by Adrian Walther licensed via SoundStripe

Episode Timestamps
• [00:00] - Introduction and episode overview
• [02:03] - Life transitions and when ADHD becomes visible in adults
• [04:14] - How ADHD can be masked by structure and support systems
• [05:21] - Red flags for ADHD in primary care settings
• [08:54] - Who can diagnose ADHD and what tools are available
• [12:05] - The importance of impairment in diagnosis and avoiding overdiagnosis
• [16:36] - Common comorbidities: Anxiety, depression, and bipolar disorder
• [19:39] - ADHD and substance use disorder
• [21:26] - Barriers to diagnosis and treatment: Stigma and misconceptions about stimulants
• [24:07] - Inequities in access to care, including Indigenous patients
• [26:26] - Challenges for rural patients and older adults with ADHD
• [29:00] - Resources and support in BC: CADRA, Shared Care, and Skills for Success
• [30:56] - ADHD pathways and UBC CPD educational opportunities
• [32:59] - Closing remarks and conference information
• [33:52] - Knowledge nugget: The history of psychostimulants

Studies & Research Mentioned
• CADDRA – Canadian ADHD Resource Alliance. Canadian ADHD Practice Guidelines, 4.1 Edition. Toronto, ON: CADDRA; 2020. Accessed January 13, 2026. https://adhdlearn.caddra.ca/wp-content/uploads/2022/08/Canadian-ADHD-Practice-Guidelines-4.1-January-6-2021.pdf
• Centers for Disease Control and Prevention. Diagnosing ADHD. Updated 2024. Accessed January 13, 2026. https://www.cdc.gov/adhd/diagnosis/index.html
• The MTA Cooperative Group: A 14-Month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder (ADHD) . Arch Gen Psychiatry 1999;56:1073-1086.
• The MTA Cooperative Group: Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder (ADHD). Arch Gen Psychiatry 1999;56:1088-1096.
• Molina BSG, Kipp HL, Joseph HM, et al. Stimulant Diversion Risk Among College Students Treated for ADHD: Primary Care Provider Prevention Training. Acad Pediatr. 2020;20(1):119-127. doi:10.1016/j.acap.2019.06.002
• National Institute of Mental Health. The Multimodal Treatment of Attention Deficit Hyperactivity Disorder Study (MTA): Questions and Answers. Revised November 2009. National Institute of Mental Health website. Accessed January 13, 2026. https://www.nimh.nih.gov/funding/clinical-research/practical/mta/the-multimodal-treatment-of-attention-deficit-hyperactivity-disorder-study-mtaquestions-and-answers
• Ramtekkar UP, Reiersen AM, Todorov AA, Todd RD. Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry. 2010;49(3):217-28.e283.

(C) 2025 UBC Medicine Learning Network


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Fri, 30 Jan 2026 08:00:00 +0000 stephen.gillis@ubc.ca (UBC Medicine Learning Network) https://cpd-in-practice.simplecast.com/episodes/s1-e3-adhd-across-life-transitions-practical-approaches-for-primary-care-w-dr-elisabeth-baerg-hall-PVJ0ErpS Guest: Dr. Elizabeth Baerg Hall
Host: Dr. Chris Morrow
Producer: Craig Ferguson
Music: "Stand With Me" by Adrian Walther licensed via SoundStripe

Episode Timestamps
• [00:00] - Introduction and episode overview
• [02:03] - Life transitions and when ADHD becomes visible in adults
• [04:14] - How ADHD can be masked by structure and support systems
• [05:21] - Red flags for ADHD in primary care settings
• [08:54] - Who can diagnose ADHD and what tools are available
• [12:05] - The importance of impairment in diagnosis and avoiding overdiagnosis
• [16:36] - Common comorbidities: Anxiety, depression, and bipolar disorder
• [19:39] - ADHD and substance use disorder
• [21:26] - Barriers to diagnosis and treatment: Stigma and misconceptions about stimulants
• [24:07] - Inequities in access to care, including Indigenous patients
• [26:26] - Challenges for rural patients and older adults with ADHD
• [29:00] - Resources and support in BC: CADRA, Shared Care, and Skills for Success
• [30:56] - ADHD pathways and UBC CPD educational opportunities
• [32:59] - Closing remarks and conference information
• [33:52] - Knowledge nugget: The history of psychostimulants

Studies & Research Mentioned
• CADDRA – Canadian ADHD Resource Alliance. Canadian ADHD Practice Guidelines, 4.1 Edition. Toronto, ON: CADDRA; 2020. Accessed January 13, 2026. https://adhdlearn.caddra.ca/wp-content/uploads/2022/08/Canadian-ADHD-Practice-Guidelines-4.1-January-6-2021.pdf
• Centers for Disease Control and Prevention. Diagnosing ADHD. Updated 2024. Accessed January 13, 2026. https://www.cdc.gov/adhd/diagnosis/index.html
• The MTA Cooperative Group: A 14-Month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder (ADHD) . Arch Gen Psychiatry 1999;56:1073-1086.
• The MTA Cooperative Group: Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder (ADHD). Arch Gen Psychiatry 1999;56:1088-1096.
• Molina BSG, Kipp HL, Joseph HM, et al. Stimulant Diversion Risk Among College Students Treated for ADHD: Primary Care Provider Prevention Training. Acad Pediatr. 2020;20(1):119-127. doi:10.1016/j.acap.2019.06.002
• National Institute of Mental Health. The Multimodal Treatment of Attention Deficit Hyperactivity Disorder Study (MTA): Questions and Answers. Revised November 2009. National Institute of Mental Health website. Accessed January 13, 2026. https://www.nimh.nih.gov/funding/clinical-research/practical/mta/the-multimodal-treatment-of-attention-deficit-hyperactivity-disorder-study-mtaquestions-and-answers
• Ramtekkar UP, Reiersen AM, Todorov AA, Todd RD. Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry. 2010;49(3):217-28.e283.

(C) 2025 UBC Medicine Learning Network


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> S1 E3: ADHD Across Life Transitions: Practical Approaches for Primary Care w/ Dr. Elisabeth Baerg Hall UBC Medicine Learning Network 00:36:11 Psychiatrist Dr. Elizabeth Baerg Hall explores adult ADHD and why it often becomes visible during major life transitions like starting university, becoming a parent, or retiring. We discuss how to recognize ADHD in primary care settings, overcome diagnostic barriers, including stigma and comorbidities like anxiety and depression, and empower family physicians to confidently diagnose and treat this highly manageable condition. From understanding the role of stimulant medications to accessing new BC resources like the Skills for Success program and upcoming ADHD pathways, this conversation highlights how recognizing and treating ADHD can profoundly improve patients' quality of life across all ages. If you’re interested in learning more about adult ADHD, visit ubccpd.ca/adult-adhd for information about our upcoming conference on March 7, 2026. Psychiatrist Dr. Elizabeth Baerg Hall explores adult ADHD and why it often becomes visible during major life transitions like starting university, becoming a parent, or retiring. We discuss how to recognize ADHD in primary care settings, overcome diagnostic barriers, including stigma and comorbidities like anxiety and depression, and empower family physicians to confidently diagnose and treat this highly manageable condition. From understanding the role of stimulant medications to accessing new BC resources like the Skills for Success program and upcoming ADHD pathways, this conversation highlights how recognizing and treating ADHD can profoundly improve patients' quality of life across all ages. If you’re interested in learning more about adult ADHD, visit ubccpd.ca/adult-adhd for information about our upcoming conference on March 7, 2026. ubc cpd, primary care, adhd, continuing professional development false full 3 1 3e728fe2-e6ec-4498-8c66-efc7d11b904d S1 E2: GLP-1s, Weight Bias and the Future of Obesity Care w/Dr. Jordanna Kapeluto Endocrinologist Dr. Jordanna Kapeluto unpacks the evolving science of obesity and the role of GLP-1 medications like semaglutide. We explore obesity as a complex, chronic disease, the impact of weight bias in health care, and the promise and pitfalls of new treatments. From mechanisms of action to real-world outcomes, this conversation challenges assumptions and highlights the importance of compassionate, evidence-based care.   

Host: Dr. Chris Morrow

Producer:  Craig Ferguson

Music: "Stand With Me" by Adrian Walther licensed via SoundStripe

(C) 2025 UBC Medicine Learning Network

Episode Timestamps

[00:00] - Introduction and episode overview

[01:38] - Medical diagnosis of obesity: Why it is important to diagnose and treat

[02:27] - Evolution of our understanding of obesity and weight dynamics

[04:30] - Stigma surrounding obesity and patient experiences of weight bias affecting access to appropriate care or diagnostics

[06:14] - Defining and diagnosing obesity

[12:40] - Discussion on GLP-1 agonists

[15:45] - GLP-1 agonists and weight loss

[18:14] - GLP-1s in diabetes treatment

[18:42] - Criteria for using GLP-1s as a weight loss agent

[22:05] - GLP-1s: Downsides and barriers

[26:50] - Guidance for primary care providers on prescribing GPL-1s

[30:27] - Closing thoughts from Dr. Jordanna Kapeluto

[31:50] - Closing remarks from Dr. Chris Morrow on GLP-1 agonists

Studies & Research Mentioned

Rubino F, Bartolomucci A, Buse JB, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;S2213-8587(24)00316-4. doi:10.1016/S2213-8587(24)00316-4

Palmer AB, Roshani R, McCormick JB, Fisher-Hoch SP, Below JE, North KE, Gordon-Larsen P. Excess Adiposity Without Obesity in a High-Risk Population. JAMA Netw Open. 2025 Oct 1;8(10):e2535194. doi: 10.1001/jamanetworkopen.2025.35194. PMID: 41042515; PMCID: PMC12495492.Drucker DJ. The GLP-1 journey: from discovery science to therapeutic impact. J Clin Invest. 2024;134(2):e175634. Published 2024 Jan 16. doi:10.1172/JCI175634 

Eng J, Kleinman WA, Singh L, Singh G, Raufman JP. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem. 1992;267(11):7402-7405.

Quetelet A. Sur l'homme et le développement de ses facultés, ou Essai de physique sociale [A Treatise on Man and the Development of His Faculties]. Bachelier; 1835.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Fri, 26 Dec 2025 08:00:00 +0000 stephen.gillis@ubc.ca (UBC Medicine Learning Network) https://cpd-in-practice.simplecast.com/episodes/s1-e2-glp-1s-weight-bias-and-the-future-of-obesity-care-w-dr-jordanna-kapeluto-H_LTWHMY Endocrinologist Dr. Jordanna Kapeluto unpacks the evolving science of obesity and the role of GLP-1 medications like semaglutide. We explore obesity as a complex, chronic disease, the impact of weight bias in health care, and the promise and pitfalls of new treatments. From mechanisms of action to real-world outcomes, this conversation challenges assumptions and highlights the importance of compassionate, evidence-based care.   

Host: Dr. Chris Morrow

Producer:  Craig Ferguson

Music: "Stand With Me" by Adrian Walther licensed via SoundStripe

(C) 2025 UBC Medicine Learning Network

Episode Timestamps

[00:00] - Introduction and episode overview

[01:38] - Medical diagnosis of obesity: Why it is important to diagnose and treat

[02:27] - Evolution of our understanding of obesity and weight dynamics

[04:30] - Stigma surrounding obesity and patient experiences of weight bias affecting access to appropriate care or diagnostics

[06:14] - Defining and diagnosing obesity

[12:40] - Discussion on GLP-1 agonists

[15:45] - GLP-1 agonists and weight loss

[18:14] - GLP-1s in diabetes treatment

[18:42] - Criteria for using GLP-1s as a weight loss agent

[22:05] - GLP-1s: Downsides and barriers

[26:50] - Guidance for primary care providers on prescribing GPL-1s

[30:27] - Closing thoughts from Dr. Jordanna Kapeluto

[31:50] - Closing remarks from Dr. Chris Morrow on GLP-1 agonists

Studies & Research Mentioned

Rubino F, Bartolomucci A, Buse JB, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;S2213-8587(24)00316-4. doi:10.1016/S2213-8587(24)00316-4

Palmer AB, Roshani R, McCormick JB, Fisher-Hoch SP, Below JE, North KE, Gordon-Larsen P. Excess Adiposity Without Obesity in a High-Risk Population. JAMA Netw Open. 2025 Oct 1;8(10):e2535194. doi: 10.1001/jamanetworkopen.2025.35194. PMID: 41042515; PMCID: PMC12495492.Drucker DJ. The GLP-1 journey: from discovery science to therapeutic impact. J Clin Invest. 2024;134(2):e175634. Published 2024 Jan 16. doi:10.1172/JCI175634 

Eng J, Kleinman WA, Singh L, Singh G, Raufman JP. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem. 1992;267(11):7402-7405.

Quetelet A. Sur l'homme et le développement de ses facultés, ou Essai de physique sociale [A Treatise on Man and the Development of His Faculties]. Bachelier; 1835.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> S1 E2: GLP-1s, Weight Bias and the Future of Obesity Care w/Dr. Jordanna Kapeluto UBC Medicine Learning Network 00:33:43 Endocrinologist Dr. Jordanna Kapeluto unpacks the evolving science of obesity and the role of GLP-1 medications like semaglutide. We explore obesity as a complex, chronic disease, the impact of weight bias in health care, and the promise and pitfalls of new treatments. From mechanisms of action to real-world outcomes, this conversation challenges assumptions and highlights the importance of compassionate, evidence-based care. Endocrinologist Dr. Jordanna Kapeluto unpacks the evolving science of obesity and the role of GLP-1 medications like semaglutide. We explore obesity as a complex, chronic disease, the impact of weight bias in health care, and the promise and pitfalls of new treatments. From mechanisms of action to real-world outcomes, this conversation challenges assumptions and highlights the importance of compassionate, evidence-based care. cpd in practice, ubc cpd, ubc cpd in practice, ubc medicine, ubc false full 2 1 e7dfdb13-5bda-460b-9576-77d7c7cfcbbf S1 E1: Generative AI in Medicine w/Dr. Sofia Valanci How is AI reshaping the future of clinical medicine? In this episode, we explore the transformative power of generative AI in healthcare with Dr. Sofia Valanci, Physician Program Advisor at the Royal College of Physicians and Surgeons of Canada. Dr. Valanci shares insights on using AI to address diagnostic uncertainty, ethical concerns when using AI for scribing, protecting patient privacy and confidentiality, the impacts of AI on planetary health, and the importance of AI literacy and education in clinical practice.

DISCLAIMER: The views expressed in this podcast are those of the speakers and do not necessarily reflect the official policy or position of UBC or the Faculty of Medicine.

Host: Dr. Chris Morrow

Producer:  Craig Ferguson

Music: "Stand With Me" by Adrian Walther licensed via SoundStripe

(C) 2025 UBC Medicine Learning Network

Episode Timestamps

[00:00] – Introduction and episode overview

[02:08] – Generative AI and how it applies to clinical medicine

[03:19] – Are clinical applications of AI effective and safe?

[05:06] – How AI is being used in clinical medicine today

[06:56] – AI scribes - what are we learning about it and how is it being received?

[10:27] – AI and why detailed prompts, context, and tone matter

[14:09] – AI hallucinations and outputs

[15:25] – Effectiveness of AI in patient education and medical literature

[17:17] – Ethical concerns and issues

[17:57] – Planetary health impacts

[18:49] – Protecting patient privacy and confidentiality

[21:39] – Navigating incorrect AI-generated patient diagnoses

[22:29] – Getting started with AI and practical tips for clinicians

[23:58] – Closing thoughts

Resources & References

Studies & Research Mentioned

Li P, Yang J, Islam MA, Ren S. Making AI less "thirsty": uncovering and addressing the secret water footprint of AI models. arXiv. Published online April 6, 2023. doi:10.48550/arXiv.2304.03271  

Doctors of BC. Reducing physician burdens: AI Scribes Pilot results. Doctors of BC website. https://www.doctorsofbc.ca/technology-digital-health/2025/reducing-physician-burdens-ai-scribes-pilot-results. Published2025. Accessed November 4, 2025.

Rajpurkar P, Irvin J, Ball RL, et al. Deep learning for chest radiograph diagnosis: a retrospective comparison of the CheXNeXt algorithm to practicing radiologists. PLoS Med. 2018;15(11):e1002686. doi:10.1371/journal.pmed.1002686


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Fri, 28 Nov 2025 08:00:00 +0000 stephen.gillis@ubc.ca (Dr. Chris Morrow, Dr. Sofia Valanci) https://cpd-in-practice.simplecast.com/episodes/generative-ai-in-medicine-c_n8DNIW How is AI reshaping the future of clinical medicine? In this episode, we explore the transformative power of generative AI in healthcare with Dr. Sofia Valanci, Physician Program Advisor at the Royal College of Physicians and Surgeons of Canada. Dr. Valanci shares insights on using AI to address diagnostic uncertainty, ethical concerns when using AI for scribing, protecting patient privacy and confidentiality, the impacts of AI on planetary health, and the importance of AI literacy and education in clinical practice.

DISCLAIMER: The views expressed in this podcast are those of the speakers and do not necessarily reflect the official policy or position of UBC or the Faculty of Medicine.

Host: Dr. Chris Morrow

Producer:  Craig Ferguson

Music: "Stand With Me" by Adrian Walther licensed via SoundStripe

(C) 2025 UBC Medicine Learning Network

Episode Timestamps

[00:00] – Introduction and episode overview

[02:08] – Generative AI and how it applies to clinical medicine

[03:19] – Are clinical applications of AI effective and safe?

[05:06] – How AI is being used in clinical medicine today

[06:56] – AI scribes - what are we learning about it and how is it being received?

[10:27] – AI and why detailed prompts, context, and tone matter

[14:09] – AI hallucinations and outputs

[15:25] – Effectiveness of AI in patient education and medical literature

[17:17] – Ethical concerns and issues

[17:57] – Planetary health impacts

[18:49] – Protecting patient privacy and confidentiality

[21:39] – Navigating incorrect AI-generated patient diagnoses

[22:29] – Getting started with AI and practical tips for clinicians

[23:58] – Closing thoughts

Resources & References

Studies & Research Mentioned

Li P, Yang J, Islam MA, Ren S. Making AI less "thirsty": uncovering and addressing the secret water footprint of AI models. arXiv. Published online April 6, 2023. doi:10.48550/arXiv.2304.03271  

Doctors of BC. Reducing physician burdens: AI Scribes Pilot results. Doctors of BC website. https://www.doctorsofbc.ca/technology-digital-health/2025/reducing-physician-burdens-ai-scribes-pilot-results. Published2025. Accessed November 4, 2025.

Rajpurkar P, Irvin J, Ball RL, et al. Deep learning for chest radiograph diagnosis: a retrospective comparison of the CheXNeXt algorithm to practicing radiologists. PLoS Med. 2018;15(11):e1002686. doi:10.1371/journal.pmed.1002686


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> S1 E1: Generative AI in Medicine w/Dr. Sofia Valanci Dr. Chris Morrow, Dr. Sofia Valanci 00:26:24 How is AI reshaping the future of clinical medicine? In this episode, we explore the transformative power of generative AI in healthcare with Dr. Sofia Valanci, Physician Program Advisor at the Royal College of Physicians and Surgeons of Canada. Dr. Valanci shares insights on using AI to address diagnostic uncertainty, ethical concerns when using AI for scribing, protecting patient privacy and confidentiality, the impacts of AI on planetary health, and the importance of AI literacy and education in clinical practice. DISCLAIMER: The views expressed in this podcast are those of the speakers and do not necessarily reflect the official policy or position of UBC or the Faculty of Medicine. How is AI reshaping the future of clinical medicine? In this episode, we explore the transformative power of generative AI in healthcare with Dr. Sofia Valanci, Physician Program Advisor at the Royal College of Physicians and Surgeons of Canada. Dr. Valanci shares insights on using AI to address diagnostic uncertainty, ethical concerns when using AI for scribing, protecting patient privacy and confidentiality, the impacts of AI on planetary health, and the importance of AI literacy and education in clinical practice. DISCLAIMER: The views expressed in this podcast are those of the speakers and do not necessarily reflect the official policy or position of UBC or the Faculty of Medicine. false full 1 1